Download full-text PDF

Source
http://dx.doi.org/10.1134/S0012496614010013DOI Listing

Publication Analysis

Top Keywords

immunization non-replicating
4
non-replicating antigen
4
antigen leads
4
leads changes
4
changes song
4
song characteristics
4
characteristics level
4
level corticosterone
4
corticosterone passerine
4
passerine birds
4

Similar Publications

Bacterial biofilms are surface-attached communities consisting of non-replicating persister cells encased within an extracellular matrix of biomolecules. Unlike bacteria that have acquired resistance to antibiotics, persister cells enable biofilms to demonstrate innate tolerance toward all classes of conventional antibiotic therapies. It is estimated that 50-80% of bacterial infections are biofilm associated, which is considered the underlying cause of chronic and recurring infections.

View Article and Find Full Text PDF

Yellow fever (YF) is a viral disease that affects both humans and non-human primates (NHPs). Neotropical monkeys are more severely stricken by YF and the impact of the disease can be devastating to the endangered golden-headed lion tamarins (GHLTs, Leontopithecus chrysomelas). Susceptible GHLTs were immunized with the commercial Brazilian YF 17DD live attenuated vaccine or two other experimental non-replicating YF vaccines: a purified whole-virus, b-propiolactone-inactivated vaccine and a plant-derived recombinant subunit vaccine.

View Article and Find Full Text PDF

Granulomas, dense clusters of immune cells and bacteria, are critical barriers in tuberculosis (TB) treatment. Recent advancements in TB management have highlighted granuloma control as a potential host-directed therapy (HDT) strategy. Although isoniazid (INH) is the first-line drug for TB therapy, its efficacy is limited to non-replicating Mycobacterium tuberculosis (Mtb) under granulomatous conditions, necessitating the development of more effective derivatives.

View Article and Find Full Text PDF

Pyrazinamide (PZA) is a critical component of tuberculosis first-line therapy due to its ability to kill both growing and non-replicating drug-tolerant populations of within the host. Recent evidence indicates that PZA acts through disruption of coenzyme A synthesis under conditions that promote cellular stress. In contrast to its bactericidal action , PZA shows weak bacteriostatic activity against in axenic culture.

View Article and Find Full Text PDF

Virus replication is not required for oncolytic bovine herpesvirus-1 immunotherapy.

Mol Ther Oncol

December 2024

Center for Discovery in Cancer Research, Department of Medicine, McMaster University, Hamilton, ON, Canada.

Article Synopsis
  • Oncolytic viruses, like bovine herpesvirus-1 (BoHV-1), are designed to selectively attack cancer cells while enhancing the body's immune response.
  • Research shows that both live and UV-inactivated (non-replicating) BoHV-1 can effectively extend the survival of mice with tumors by promoting similar immune cell infiltration, excluding neutrophils.
  • Additionally, transcriptomic analysis indicates that both forms of BoHV-1 activate similar biological pathways and gene expressions, challenging the idea that viral replication is essential for their therapeutic benefits.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!